Regional heterogeneity in expression of the sphingosine-1-phosphate pathway in the female rat lower urinary tract.

[1]  S. Milstien,et al.  Autocrine and paracrine roles of sphingosine-1-phosphate , 2007, Trends in Endocrinology & Metabolism.

[2]  S. Payne,et al.  Sphingosine‐1‐phosphate and the immunosuppressant, FTY720‐phosphate, regulate detrusor muscle tone , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  A. Huwiler,et al.  Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. , 2007, Critical reviews in oncology/hematology.

[4]  E. Colli,et al.  Overactive bladder treatments in early phase clinical trials , 2007, Expert opinion on investigational drugs.

[5]  S. Macdiarmid,et al.  Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached? , 2007, BJU international.

[6]  M. Gräler,et al.  Erythrocytes store and release sphingosine 1‐phosphate in blood , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  S. Milstien,et al.  Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. , 2006, Biochimica et biophysica acta.

[8]  M. Gräler,et al.  Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. , 2006, Analytical biochemistry.

[9]  R. Sabbadini,et al.  Targeting sphingosine-1-phosphate for cancer therapy , 2006, British Journal of Cancer.

[10]  K. Murthy,et al.  Characterization of S1P1 and S1P2 receptor function in smooth muscle by receptor silencing and receptor protection. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[11]  T. Wagner,et al.  Health‐related consequences of overactive bladder: an economic perspective , 2005, BJU international.

[12]  E. Goetzl,et al.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network , 2005, Nature Reviews Immunology.

[13]  S. Davidge,et al.  Sphingosine 1‐phosphate‐induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats , 2004, British journal of pharmacology.

[14]  M. Michel,et al.  Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. , 2004, Autonomic & autacoid pharmacology.

[15]  K. Andersson.  Detrusor contraction , 2004, Scandinavian journal of urology and nephrology. Supplementum.

[16]  M. Vadas,et al.  Sphingosine kinase transmits estrogen signaling in human breast cancer cells. , 2003, Molecular endocrinology.

[17]  J. Reynard,et al.  Nitric oxide and the lower urinary tract: current concepts, future prospects. , 2003, Urology.

[18]  M. Moskowitz,et al.  S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. , 2003, European journal of pharmacology.

[19]  J. Chun,et al.  Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3* , 2002, The Journal of Biological Chemistry.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  T. Michel,et al.  Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide Synthase , 2001, The Journal of Biological Chemistry.

[22]  T. Hla,et al.  Differential Pharmacological Properties and Signal Transduction of the Sphingosine 1-Phosphate Receptors EDG-1, EDG-3, and EDG-5* , 1999, The Journal of Biological Chemistry.

[23]  U. Förstermann,et al.  Differential distribution of nitric oxide synthase in neural pathways to the urogenital organs (urethra, penis, urinary bladder) of the rat , 1994, Brain Research.